Form 4: Hims & Hers Health Chief Legal Officer Reports Stock Option Exercises and Sales

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On January 6, 2025, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., executed transactions involving the company's Class A Common Stock.
• Boughton exercised stock options to acquire 113,768 shares at $2.43 and 140,255 shares at $5.01.
• Concurrently, Boughton sold 238,932 shares at $27.72 and 30,000 shares at $28.
• Following these transactions, Boughton directly owns 169,803 shares of Class A Common Stock.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy and do not necessarily reflect a change in the executive's confidence in the company.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, suggesting they were planned well in advance and not based on immediate insider information.

Risks

• Executive stock sales could be perceived negatively by investors, potentially impacting the stock price, although the 10b5-1 plan mitigates this concern.

Industry Context

Insider trading activity is always closely watched in the pharmaceutical and telehealth industries, as these companies are often subject to intense regulatory scrutiny and market volatility.

Comparison to Industry Standards

• Comparing Boughton's transactions to similar filings by executives at companies like Teladoc Health or GoodRx could provide context on whether these actions are typical for the industry.
• The use of a 10b5-1 plan is a common practice among corporate executives to avoid accusations of insider trading, aligning with industry best practices.

Stakeholder Impact

• Shareholders may scrutinize the transactions for any potential implications on the company's performance.
• Employees may be interested in the executive's stock activity as an indicator of company health.

Key Dates